Caring for cancer survivors: More than just checking the blood pressure and measuring the ejection fraction

Future Cardiology

Volumn 11, Issue 4, 2015, Pages 371-375

  Mulrooney, Daniel A ^a,b   A Duprez, Daniel ^c  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Arterial stiffness; Atherosclerosis; Blood pressure; Cancer survivors; Cardiovascular disease; Ejection fraction; Endothelial dysfunction; Surveillance

Indexed keywords

ADVANCED CANCER; BLOOD PRESSURE MEASUREMENT; CANCER SURVIVAL; CANCER SURVIVOR; CARDIOVASCULAR EFFECT; HEART EJECTION FRACTION; HUMAN; MEDICAL RESEARCH; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SCREENING TEST; CARDIOTOXICITY; CARDIOVASCULAR DISEASES; COMPLICATION; MORTALITY; NEOPLASMS;

CARDIOTOXICITY; CARDIOVASCULAR DISEASES; HUMANS; NEOPLASMS;

EID: 84939456676     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/FCA.15.45     Document Type: Review

References (27)

1. Floyd JD, Nguyen DT, Lobins RL, Bashir Q, Doll DC, Perry MC. Cardiotoxicity of cancer therapy. J. Clin. Oncol. 23(30), 7685-7696 (2005).
2. Swain SM, Whaley FS, Ewer MS. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer 97(11), 2869-2879 (2003).
3. Lipshultz SE, Lipsitz SR, Mone SM et al. Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N. Engl. J. Med. 332(26), 1738-1743 (1995).
4. Nysom K, Holm K, Lipsitz SR et al. Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia. J. Clin. Oncol. 16(2), 545-550 (1998).
5. Mulrooney DA, Yeazel MW, Kawashima T et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ 339, b4606 (2009).
6. Seidman A, Hudis C, Pierri MK et al. Cardiac dysfunction in the trastuzumab clinical trials experience. J. Clin. Oncol. 20(5), 1215-1221 (2002).
7. Guglin M, Hartlage G, Reynolds C, Chen R, Patel V. Trastuzumab-induced cardiomyopathy: not as benign as it looks? A retrospective study. J. Card. Fail. 15(8), 651-657 (2009).
8. Hancock SL, Tucker MA, Hoppe RT. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 270(16), 1949-1955 (1993).
9. Darby SC, Ewertz M, Mcgale P et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N. Engl. J. Med. 368(11), 987-998 (2013).
10. Landier W, Bhatia S, Eshelman DA et al. Development of risk-based guidelines for pediatric cancer survivors: the hildren's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J. Clin. Oncol. 22(24), 4979-4990 (2004).
11. Armstrong GT, Oeffinger KC, Chen Y et al. Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. J. Clin. Oncol. 31(29), 3673-3680 (2013).
12. Brouwer CA, Postma A, Hooimeijer HL et al. Endothelial damage in long-term survivors of childhood cancer. J. Clin. Oncol. 31(31), 3906-3913 (2013).
13. Van Leeuwen-Segarceanu EM, Dorresteijn LD, Vogels OJ, Biesma DH, Bos WJ. Arterial stiffness is increased in Hodgkin lymphoma survivors treated with radiotherapy. Leuk. Lymphoma 54(8), 1734-1741 (2013).
14. Malhotra J, Tonorezos ES, Rozenberg M et al. Atherogenic low density lipoprotein phenotype in long-term survivors of childhood acute lymphoblastic leukemia. J. Lipid Res. 53(12), 2747-2754 (2012).
15. Cardinale D, Sandri MT, Colombo A et al. Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy. Circulation 109(22), 2749-2754 (2004).
16. Morris PG, Chen C, Steingart R et al. Troponin I and C-reactive protein are commonly detected in patients with breast cancer treated with dose-dense chemotherapy incorporating trastuzumab and lapatinib. Clin. Cancer. Res. 17(10), 3490-3499 (2011).
17. Ky B, Putt M, Sawaya H et al. Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab. J. Am. Coll. Cardiol. 63(8), 809-816 (2014).
18. Lipshultz SE, Landy DC, Lopez-Mitnik G et al. Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy. J. Clin. Oncol. 30(10), 1050-1057 (2012).
19. Brouwer CA, Postma A, Vonk JM et al. Systolic and diastolic dysfunction in long-term adult survivors of childhood cancer. Eur. J. Cancer 47(16), 2453-2462 (2011).
20. Sanchez OA, Jacobs DR Jr, Bahrami H et al. Increasing aminoterminal-pro-B-type natriuretic peptide precedes the development of arterial hypertension: the multiethnic study of atherosclerosis. J. Hypertens. 33(5), 966-974 (2015).
21. Greenland P, Alpert JS, Beller GA et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 56(25), e50-103 (2010).
22. Meeske KA, Siegel SE, Gilsanz V et al. Premature carotid artery disease in pediatric cancer survivors treated with neck irradiation. Pediatr. Blood Cancer 53(4), 615-621 (2009).
23. Smith WA, Li C, Nottage KA et al. Lifestyle and metabolic syndrome in adult survivors of childhood cancer: a report from the st. Jude lifetime cohort study. Cancer 120(17), 2742-2750 (2014).
24. Tonorezos ES, Robien K, Eshelman-Kent D et al. Contribution of diet and physical activity to metabolic parameters among survivors of childhood leukemia. Cancer Causes Control 24(2), 313-321 (2013).
25. Ridker PM, Danielson E, Fonseca FA et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N. Engl. J. Med. 359(21), 2195-2207 (2008).
26. Duprez DA. Is vascular stiffness a target for therapy? Cardiovasc. Drugs Ther. 24(4), 305-310 (2010).
27. Mahmud A, Feely J. Antihypertensive drugs and arterial stiffness. Expert Rev. Cardiovasc. Ther. 1(1), 65-78 (2003).